Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Yodoi

Showing results (161-170 of 269) with videos related to

Pageof 27
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1992
ADF (adult T cell leukemia-derived factor)/human thioredoxin and viral infection: possible new therapeutic approachH Masutani, H Nakamura, Y Ueda, et al.
Journal of Immunological Methods|November 20, 1986
A human T cell line established from a patient with Sézary syndrome. Application for assay of human interleukin 2 (IL-2)S Namiuchi, S Kumagai, H Sano, et al.
The Journal of Experimental Medicine|December 1, 1985
Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangementM Maeda, A Shimizu, K Ikuta, et al.
Allergy|February 12, 2009
Thioredoxin reduces C-C chemokine-induced chemotaxis of human eosinophilsN Kobayashi, Y Yamada, W Ito, et al.
Antioxidants & Redox Signaling|March 10, 2001
Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinaseJ Takeuchi, K Hirota, T Itoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Construction of rat-mouse T cell hybridomas that express regulatable rat interleukin 2 receptorH Kohda, T Uede, H Yuasa, et al.
Journal of Clinical Immunology|November 1, 1996
IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytesA Morinobu, S Kumagai, H Yanagida, et al.
Journal of Leukocyte Biology|January 14, 1999
Significant expression of G-CSF-induced gene-1 (GIG-1) protein in myeloid cells and NK cellsM Shimane, K Tani, H Hibino, et al.
Biochemical and Biophysical Research Communications|September 7, 2000
Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytesK Hirota, H Nakamura, T Arai, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damageY Takagi, A Mitsui, A Nishiyama, et al.
Pageof 27

Showing results (161-170 of 269) with videos related to

Sort By:
Pageof 27
Advances in Experimental Medicine and Biology|January 1, 1992
ADF (adult T cell leukemia-derived factor)/human thioredoxin and viral infection: possible new therapeutic approachH Masutani, H Nakamura, Y Ueda, et al.
Journal of Immunological Methods|November 20, 1986
A human T cell line established from a patient with Sézary syndrome. Application for assay of human interleukin 2 (IL-2)S Namiuchi, S Kumagai, H Sano, et al.
The Journal of Experimental Medicine|December 1, 1985
Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangementM Maeda, A Shimizu, K Ikuta, et al.
Allergy|February 12, 2009
Thioredoxin reduces C-C chemokine-induced chemotaxis of human eosinophilsN Kobayashi, Y Yamada, W Ito, et al.
Antioxidants & Redox Signaling|March 10, 2001
Thioredoxin inhibits tumor necrosis factor- or interleukin-1-induced NF-kappaB activation at a level upstream of NF-kappaB-inducing kinaseJ Takeuchi, K Hirota, T Itoh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Construction of rat-mouse T cell hybridomas that express regulatable rat interleukin 2 receptorH Kohda, T Uede, H Yuasa, et al.
Journal of Clinical Immunology|November 1, 1996
IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytesA Morinobu, S Kumagai, H Yanagida, et al.
Journal of Leukocyte Biology|January 14, 1999
Significant expression of G-CSF-induced gene-1 (GIG-1) protein in myeloid cells and NK cellsM Shimane, K Tani, H Hibino, et al.
Biochemical and Biophysical Research Communications|September 7, 2000
Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytesK Hirota, H Nakamura, T Arai, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damageY Takagi, A Mitsui, A Nishiyama, et al.
Pageof 27